IFNA1 and glioblastoma: However, the absence of ISG induction in differentiated HF2927 cells underscores the heterogeneity in GBM CSC responses, emphasizing the need for further studies using larger panels of patient-derived models to assess the prevalence of endogenous ISG activation in differentiated CSCs and the effects of IFN treatment on CSC differentiation.